Gerrit Dispersyn - Feb 15, 2022 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
President & CEO, Director
Signature
Caitlin Kontulis, attorney-in-fact
Stock symbol
PHIO
Transactions as of
Feb 15, 2022
Transactions value $
$0
Form type
4
Date filed
2/16/2022, 07:03 PM
Previous filing
Aug 17, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Award $0 +126K +132.24% $0.00 221K Feb 15, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments.
F2 Includes shares of common stock underlying unvested restricted stock units.